Name: INBX Balance Sheet - Inhibrx Biosciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

INBX - Inhibrx Biosciences, Inc.

USD | NASDAQ | Healthcare

INBX Balance Sheet - Inhibrx Biosciences Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	161.7	124.2	153.1	186.6	216.5	152.6	196.3	226.9	-	277.9	-	-	-	-
Restricted Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	161.7	124.2	153.1	186.6	216.5	152.6	196.3	226.9	-	277.9	-	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses
Non-Current Assets
Property, Plant & Equipment Gross	14.9	14.9	14.9	15.1	15.1	15.1	15.1	15.1	-	13.1	-	-	-	-
Current Liabilities
Accounts Payable	8.8	5.9	6.8	8.3	8.9	9.2	12.4	13.0	-	11.0	-	-	-	-
Short Term Debt
Non-Current Liabilities
Long Term Debt	175.0	100.6	99.9	99.3	98.7	0.0	0.0	0.0	-	207.0	-	-	-	-
Operating Lease Liabilities Non-Current
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	0.0	-	-	-	-
Additional Paid In Capital
Supplementary Data
Total Debt	175.0	100.6	99.9	99.3	98.7	0.0	0.0	0.0	-	207.0	-	-	-	-
Net debt

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	124.2	152.6	277.9	-
Restricted Cash	-	-	-	-
Short Term Investments	-	-	-	-
Cash And Short Term Investments	124.2	152.6	277.9	-
Receivables
Accounts Receivable	-	-	-	-
Current Assets
Inventory	-	-	-	-
Prepaid Expenses	8.4	7.4	16.7	-
Other Current Assets	0.2	0.4	0.4	-
Non-Current Assets
Property, Plant & Equipment Gross	14.9	15.1	13.1	-
Accumulated Depreciation	11.1	8.9	6.7	-
Property,Plant & Equipment Net	3.7	6.2	6.4
Current Liabilities
Accounts Payable	5.9	9.2	11.0	-
Short Term Debt	-	-	-	-
Deferred Revenue Current	-	-	-	-
Non-Current Liabilities
Long Term Debt	100.6	0.0	207.0	-
Operating Lease Liabilities Non-Current	4.1	6.5	1.1	-
Deferred Revenue Non-Current	-	-	-
Common Equity
Common Stock	0.0	0.0	0.0	-
Additional Paid In Capital	254.2	239.7	657.2	-
Retained Earnings	(246.2)	(106.1)	(613.7)
Supplementary Data
Total Debt	100.6	0.0	207.0	-
Net debt	(23.7)	(152.6)	(71.0)	-
Working Capital	99.0	119.7	239.0	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)